世界の性感染症（STD）の治療市場：市場規模・現状・予測

• 英文タイトル：Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N8027
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・性感染症（STD）の治療の世界市場規模
・主要企業別市場シェア
・性感染症（STD）の治療の世界市場規模：種類別（ウイルス感染、細菌感染、その他）
・性感染症（STD）の治療の世界市場規模：用途別（病院、診療所、その他）
・性感染症（STD）の治療のアメリカ市場規模（種類別、用途別）
・性感染症（STD）の治療のヨーロッパ市場規模（種類別、用途別）
・性感染症（STD）の治療の中国市場規模（種類別、用途別）
・性感染症（STD）の治療の日本市場規模（種類別、用途別）
・性感染症（STD）の治療の東南アジア市場規模（種類別、用途別）
・性感染症（STD）の治療のインド市場規模（種類別、用途別）
・性感染症（STD）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・性感染症（STD）の治療の世界市場予測（2019年-2025年）
・性感染症（STD）の治療の地域別市場予測（2019年-2025年）
...

Sexually transmitted diseases (STD), are infections that are commonly spread by sexual activity. Many times STD initially do not cause symptoms, this results in a greater risk of passing the disease on to others.In 2018, the global Sexually Transmitted Diseases (STD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sexually Transmitted Diseases (STD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexually Transmitted Diseases (STD) Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bayer
Bristol-Myers Squibb
Eli Lilly

Market segment by Type, the product can be split into
Viral Infections
Bacterial Infections
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sexually Transmitted Diseases (STD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Sexually Transmitted Diseases (STD) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sexually Transmitted Diseases (STD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Viral Infections
1.4.3 Bacterial Infections
1.4.4 Others
1.5 Market by Application
1.5.1 Global Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sexually Transmitted Diseases (STD) Treatment Market Size
2.2 Sexually Transmitted Diseases (STD) Treatment Growth Trends by Regions
2.2.1 Sexually Transmitted Diseases (STD) Treatment Market Size by Regions (2014-2025)
2.2.2 Sexually Transmitted Diseases (STD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sexually Transmitted Diseases (STD) Treatment Market Size by Manufacturers
3.1.1 Global Sexually Transmitted Diseases (STD) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sexually Transmitted Diseases (STD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Sexually Transmitted Diseases (STD) Treatment Key Players Head office and Area Served
3.3 Key Players Sexually Transmitted Diseases (STD) Treatment Product/Solution/Service
3.4 Date of Enter into Sexually Transmitted Diseases (STD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019)
4.2 Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
5.2 Sexually Transmitted Diseases (STD) Treatment Key Players in United States
5.3 United States Sexually Transmitted Diseases (STD) Treatment Market Size by Type
5.4 United States Sexually Transmitted Diseases (STD) Treatment Market Size by Application

6 Europe
6.1 Europe Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
6.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Europe
6.3 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Type
6.4 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Application

7 China
7.1 China Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
7.2 Sexually Transmitted Diseases (STD) Treatment Key Players in China
7.3 China Sexually Transmitted Diseases (STD) Treatment Market Size by Type
7.4 China Sexually Transmitted Diseases (STD) Treatment Market Size by Application

8 Japan
8.1 Japan Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
8.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Japan
8.3 Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Type
8.4 Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
9.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Type
9.4 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Application

10 India
10.1 India Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
10.2 Sexually Transmitted Diseases (STD) Treatment Key Players in India
10.3 India Sexually Transmitted Diseases (STD) Treatment Market Size by Type
10.4 India Sexually Transmitted Diseases (STD) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size (2014-2019)
11.2 Sexually Transmitted Diseases (STD) Treatment Key Players in Central & South America
11.3 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Type
11.4 Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.1.4 Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.2.4 Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Gilead Sciences
12.3.1 Gilead Sciences Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.3.4 Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.3.5 Gilead Sciences Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.4.4 GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.6.4 Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.6.5 Merck Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.7.4 AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Bayer
12.8.1 Bayer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.8.4 Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.8.5 Bayer Recent Development
12.9 Bristol-Myers Squibb
12.9.1 Bristol-Myers Squibb Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.9.4 Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.9.5 Bristol-Myers Squibb Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sexually Transmitted Diseases (STD) Treatment Introduction
12.10.4 Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
12.10.5 Eli Lilly Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Sexually Transmitted Diseases (STD) Treatment Key Market Segments
Table Key Players Sexually Transmitted Diseases (STD) Treatment Covered
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size Market Share by Type 2014-2025
Figure Viral Infections Figures
Table Key Players of Viral Infections
Figure Bacterial Infections Figures
Table Key Players of Bacterial Infections
Figure Others Figures
Table Key Players of Others
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Sexually Transmitted Diseases (STD) Treatment Report Years Considered
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2025 (Million US$)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Sexually Transmitted Diseases (STD) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Share by Manufacturers in 2018
Table Global Sexually Transmitted Diseases (STD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sexually Transmitted Diseases (STD) Treatment Product/Solution/Service
Table Date of Enter into Sexually Transmitted Diseases (STD) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Type (2014-2019)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size Market Share by Type (2014-2019)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Application (2014-2019)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Application in 2018
Figure United States Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table United States Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table United States Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure Europe Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure China Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table China Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table China Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure Japan Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table Japan Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure India Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table India Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table India Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Figure Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sexually Transmitted Diseases (STD) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sexually Transmitted Diseases (STD) Treatment Market Share (2018-2019)
Table Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sexually Transmitted Diseases (STD) Treatment Market Share by Type (2014-2019)
Table Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sexually Transmitted Diseases (STD) Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Roche Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Merck Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Bayer Company Details
Table Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Regions (2019-2025)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size Share by Regions in 2025
Figure United States Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sexually Transmitted Diseases (STD) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size by Product (2019-2025)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size by Product in 2025
Table Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2019-2025)
Figure Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の性感染症（STD）診断市場：市場規模・現状・予測

Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Status and Forecast 2019-2025
QYR9N8026 2019年6月14日 108Pages
当資料は、性感染症（STD）診断のグローバル市場について調査・分析したレポートで、種類別（クラミジアテスト、梅毒検査、淋病テスト、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、その他）、用途別（政府機関、病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米...

世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測

Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
QYR9N8091 2019年6月14日 98Pages
当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...

世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7362 2019年6月14日 98Pages
当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7871 2019年6月14日 92Pages
当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測

Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7216 2019年6月14日 92Pages
当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7488 2019年6月14日 97Pages
当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測

Global Inflammatory Skin Diseases Treatment Market Size, Status and Forecast 2019-2025
QYR9N7365 2019年6月14日 97Pages
当資料は、炎症性皮膚疾患の治療のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連...

世界の炎症性皮膚疾患薬市場：市場規模・現状・予測

Global Inflammatory Skin Diseases Drugs Market Size, Status and Forecast 2019-2025
QYR9N7364 2019年6月14日 93Pages
当資料は、炎症性皮膚疾患薬のグローバル市場について調査・分析したレポートで、種類別（レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界の奇病市場：市場規模・現状・予測

Global Orphan Diseases Market Size, Status and Forecast 2019-2025
QYR9N7723 2019年6月14日 94Pages
当資料は、奇病のグローバル市場について調査・分析したレポートで、種類別（自己免疫疾患、遺伝性疾患、血液疾患、がん、成長障害、その他）、用途別（病院と診療所、研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の口腔疾患の治療市場：市場規模・現状・予測

Global Oral Diseases Treatments Market Size, Status and Forecast 2019-2025
QYR9N7716 2019年6月14日 90Pages
当資料は、口腔疾患の治療のグローバル市場について調査・分析したレポートで、種類別（虫歯、歯周病、外傷、口腔がん）、用途別（病院、診療所、医学研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の性感染症（STD）診断市場：市場規模・現状・予測 Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses.Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of aw…
世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測 Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.In 2018, the glo…
世界の炎症性皮膚疾患の治療市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Treatment status, future forecast, growth opportuni…
世界の奇病市場：市場規模・現状・予測 An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
世界の口腔疾患の治療市場：市場規模・現状・予測 Oral diseases ranging from cavities to cancer are all serious threats to your oral health.In 2018, the global Oral Diseases Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global …